This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

Annual Report and Accounts for Year End March 2023

P2 Message from the Director P3-P4 Achievements & Highlights 2022-2023

P5-P6 What our partners say about us P7-P11 Areas of work P12 Anti-Oppression Framework P12-P14 Media Coverage

P15 Membership Engagement P16 Hosting Role P17-P18 Plans for 2023-24 P19 Staff Team

P20-p23 Structure, Governance and Management P24-p25 Financial review P26 Auditor’s Report

Message from the Director

Over the last year STOPAIDS has focused on implementing our 2022-2025 Organisational Strategy which we officially launched in September 2022. The way that we work, in partnership with members, global partners, and other key stakeholders to advance our advocacy objectives, remains as important as ever and is vital to upholding the values enshrined in our anti-oppression framework, which underpins our strategy and informs all aspects of our work.

Over 2022 and into 2023, the broader UK and global contexts were highly challenging to navigate. The impact of the COVID-19 pandemic and the inequality of the global response to it were continuing to sink in and condense in geo-politics, reverberating across societies, economies and health systems. The global focus on pandemic preparation, prevention and response continued apace – with the often-rushed creation of new institutions and the beginning of complicated negotiations around global PPPR regulation. The UK political context was particularly chaotic with multiple changes of Government, Prime Ministers, Foreign Secretaries and Development Ministers that made government and parliamentary engagement very challenging.

Within the development sector the decolonisation movement gained some momentum and we helped to expand our awareness and learning about systemic inequality and continued to inform our understanding of our position as a UK-based organisation and how we conduct our advocacy. We believe that there is a great opportunity here to make a paradigm shift in consciousness of and action on oppression and power and we will continue to prioritise this work into 2023 and 2024.

From an internal perspective, throughout much of 2022 we focused on consolidating the organisational growth that we experienced the previous year. We started an organisational review across our advocacy and internal functions, identifying key gaps and areas for renewal or development. We further updated our financial systems to meet the demands of a medium sized charity and put enhanced focus on ensuring our continued financial sustainability through fundraising. It has been a difficult environment in the context of funding for work on global health and we have worked to diversify our funding streams, adapt our strategy to the new funding landscape, and further develop how we articulate our value and impact. We also conducted a comprehensive review of our systems and HR policies to ensure that they were fit for purpose and reflected the values and culture of STOPAIDS.

Overall, STOPAIDS has had a productive year despite a turbulent UK political environment and major transitions at global level. I am pleased with how STOPAIDS is using its new strategy and anti-oppression framework to achieve ever more systemic change towards ending AIDS and to hold itself and its work ever more accountable to those most affected by HIV and broader health conditions and partners in low- and middle-income countries. Looking forward, I am confident that we have an excellent team and Board of Trustees in place who will work together to deliver on our ambitious strategy and prove that collaborative advocacy is a powerful tool for change.

Mike Podmore

Achievements & highlights 2022-2023

People over Profit

In 2022 we continued to work on the TRIPS waiver by mobilising the Missing Medicines Coalition and People’s Vaccine Alliance to lobby against the UK Government’s regressive suggestions to the text in the waiver. Over the course of several months, we engaged with civil servants in the Department for International Trade and the Intellectual Property Office and presented evidence to support an extension of the TRIPS waiver outcome to include COVID-19 tests and treatments. We continued to maintain cross-party support for the TRIPS waiver. 32 cross-party parliamentarians attended our pre-MC12 photo-op session in Parliament calling for the UK Government to support the waiver. We secured Labour frontbench support for equitable access to vaccines, diagnostics and therapeutics.
We increased our access to medicines engagement in current pandemic preparedness discussions, by engaging in WHO Pandemic Accord processes and providing oral and written statements to public hearings, attending civil society consultations with UK Government, and submitting additional resources and written evidence to civil servants.
Additionally, we worked with a wide range of stakeholders to develop high-quality resources on access to medicines, notably our Access Denied report series. In line with our report’s recommendations, we were also pleased that the COVI Committee report made recommendations related to enhancing transparency regarding price, public vaccine funding and procurement and the real costs of R&D, and the Commission proposed to create an EU-wide compulsory licensing instrument in crisis situations that have an EU-wide impact.
As a result of our parliamentary events to launch the UK reports we secured positive response and interest from stakeholders in wanting to support taking forward the report recommendations, including with cross-party parliamentarians and senior civil servants from the UK’s Department for Health & Social Care; Department for Business and Trade; and the Foreign, Commonwealth and Development Office.
We also continued to advance our work as a member of the Digital Health and Rights Project (DHRP) consortium with a particular focus on improving young participants’ knowledge of digital health and rights and promoting emerging learnings and recommendations from our ongoing research in Vietnam, Kenya and Ghana. The DHRP launched its new joint research report into young people’s experiences of digital health technologies from Vietnam, Ghana and Bangladesh. STOPAIDS also coordinated the development of two joint submissions for the UN Special Rapporteur (UNSR) on the right to health’s upcoming report on ‘Digital technologies, innovation and the right to health’. As a result, we increased the participation of young people and civil society in shaping digital health governance.
Finally, we officially launched our Principles for ODA-funded Private Sector Engagement in Global Health which we developed in collaboration with members and other civil society networks. A particular highlight was a webinar we coorganised as part of the World Bank Civil Society Policy Forum 2022, entitled ‘The Bank’s Investments in Private Healthcare Provision: What implications for the right to health?’ where we presented on the principles.

Achievements & highlights 2022-2023

Ensuring Enhanced Quality of Life for people living with and affected by HIV.

We chaired the UK Global Fund Replenishment Working Group, coordinating a replenishment campaign that built and mobilized parliamentary and public support for the global fund. In November, Andrew Mitchell announced a UK pledge of £1 billion to The Global Fund. Whilst this was a very disappointing reduction of 30%, FCDO staff and Minister Mitchell credited our campaign with providing the key pressure necessary to boost the end pledge from a planned 800 million to 1 bn.
We also advocated for increased funding support for UNITAID and worked to build the visibility of Unitaid amongst UK parliamentarians and UK civil society. Through ongoing engagement with parliamentarians (through briefings, meetings and targeted questions), FCDO officials and the media (through op-eds) on the importance of continued commitment to Unitaid, our work contributed to the UK’s confirmed funding commitment to Unitaid for this year of 14 million.
Throughout 2022 we continued to work with the Quality of life partnership, focusing on key advocacy opportunities including AIDS2022. We hosted an event titled Making the Fourth 90 a priority in HIV policy and clinical care: A roundtable of policymakers and HIV clinicians at the AIDS 2022 Conference where we promoted the concept of quality of life and discussed how our organisation focuses on quality of life as a key advocacy area.

Transforming aid, solidarity and development co – operation

In 2022 STOPAIDS became a founding member of the Global Public Investment network (GPIN). Throughout 2022 and into early 2023, we worked on further developing the principles for meaningful involvement of civil society and communities which will provide a undamental pillar of the ‘All Decide’ principle. At the international level we promoted the Global Public Investment fundamental pillar of the ‘All Decide’ principle. At the international level we

promoted the Global Public Investment (GPI) principles with C7 Health Equality working group, in the creation of the Pandemic Fund and in the development of the process to input into the Pandemic Accord.

At the UK level, STOPAIDS co-ordinated with a few other civil society actors to promote the concept of GPI with key parliamentary figures, particularly the Labour shadow bench, and feeding into select committee and APPG inquires. We also engaged with FCDO staff to build their awareness, including through attendance at a conference on GPI at Wilton Park.

In our inclusive governance work we further developed the ACT-A Platform for Civil Society and Community Representatives (with GFAN and Waci Health) and continued to support 48 civil society and community representatives within the Access to Covid Technologies– Accelerator (ACT-A) to have meaningful involvement and positively influence the impact of the ACT-A on the pandemic. We were on the review panel for and organised civil society inputs into the final evaluation of ACT-A. We also conducted an external evaluation of the Platform for Civil Society and Community Representatives that found that the Platform had a significant impact by “providing systematic representation across all pillars and working groups of the ACT-A; increasing the ACT-A’s accountability and effectiveness; and providing a model for ensuring strong standards of meaningful involvement of civil society and communities in global health initiatives.”

We also led global advocacy to make the case for and successfully secure two civil society voting seats at the newly established Pandemic Fund (when originally there were no seats for civil society included). We ran the open selection process to identify both interim and permanent Board Members for the Global North Constituency and led work with others to establish a civil society constituency to support the global south and global north Board members.

What our partners say about us

“STOPAIDS has continued to organise and galvanise UK NGOs working on global health across the last year, in the tricky context of less funding for access work as the global gaze has shifted away from global health. STOPAIDS has continued to beat the drum for crucial advocacy on access to medicines, collaborating and coordinating with other civil society organisations to lobby the UK government for maximum impact. The

enduring work of STOPAIDS has meant that even in the context of diminishing resources, we have continued to hold the government's feet to the fire around crucial pieces of access to medicines legislation and policy. The consummate professionalism and passion of the team has meant that - as ever - STOPAIDS has been a delight to work with across the last year.”

Oxfam GB

“STOPAIDS plays an essential role in convening civil society and community partners to strategize on joint advocacy actions. Through the organization’s wide-ranging partnerships, partners are brought together to get the most bang for our buck with our messaging and get alignment among civil society to have the most impact.”

AVAC

“STOPAIDS has been doing an amazing job as leader, coordinator and convenor of UK civil society organisations on access to medicines. It has been playing a critical role in instigating and supporting critical work such as the campaign on the TRIPS waiver and on access to medicines for HIV. It has been a great coordinator of CS work around the pandemic accord and equitable access to medical technologies. Its work also extends to foster innovative ideas like the Global Public Investment. Their advocacy, media and networking capacity extends to cover UK institutions and beyond. STOPAIDS has an amazing capacity to attract brilliant staff. It is very rewarding and is also a great pleasure to work with STOPAIDS staff.”

Peoples Vaccine Alliance

“STOPAIDS take initiative in youth engagement within the HIV space, by supporting Youth Stop AIDS specifically with advocacy and campaigning, through the engagement of decision makers and stakeholders.”

Restless Development

“We really value being a member of STOPAIDS, to be able to contribute to joint strategic discussions and collaborate with other organisations working towards our common objective. STOPAIDS are always thinking one step ahead to ensure the right people are in the room and that everyone’s voice is heard.”

Avert

“STOPAIDS is an excellent organisation - from their partnering, convening and campaigning skills, they are a valuable partner in the global health and international development sectors. Their expertise in the sector - particularly on access to medicines - alongside their creative approaches to advocacy mean they are a key ally, and a joy to work with!”

Malaria No more

"STOPAIDS are invaluable partners in the fight against big pharma for more equitable health systems. They coordinate the missing medicines coalition with dedication, organisation and strategic good sense. The organisation is a brilliant repository of advocacy ideas and comms tips. STOPAIDS staff are always generous with their time and knowledge. It's difficult to imagine doing this work without them."

Just Treatment

Areas of work

The STOPAIDS 2022-2025 strategy has three advocacy impact areas: People over Profit, Quality of Life and Transforming Aid, Solidarity and Development Cooperation.

People over Profit

Campaign stunt at Pfizer HQ with member Global Justice Now

A public-health driven model for researching and developing affordable, safe and effective health technologies for all.

In 2022 we continued to work on the TRIPS waiver by mobilising the Missing Medicines Coalition and People’s Vaccine Alliance to lobby against the UK Government’s regressive suggestions to the text in the waiver. One area of focus related to the extension in the text to therapeutics and diagnostics. Over the course of several months, we engaged with civil servants in the Department for International Trade and the Intellectual Property Office and presented evidence to support an extension of the TRIPS waiver outcome to include COVID-19 tests and treatments. We continued to maintain cross-party support for the TRIPS waiver. 32 cross-party parliamentarians attended our pre-MC12 photo-op session in Parliament calling for the UK Government to support the waiver. We secured Labour frontbench support for equitable access to vaccines, diagnostics and therapeutics. We also contributed to a Bureau for Investigative Journalism article on pharmaceutical industry influence in the initial TRIPS negotiation process and met with civil servants and presented research conducted by the People’s Vaccine Alliance.

In 2022 we also started to increase our access to medicines engagement in current pandemic preparedness discussions, by engaging in WHO Pandemic Accord processes and providing oral and written statements to public hearings, attending civil society consultations with UK Government, and submitting additional resources and written evidence to civil servants. We focused on issues around ensuring equitable access as a core component of future PPR instruments. We engaged in the WHO Intergovernmental Negotiating Body (INB) process and built parliamentary awareness and support of the INB by hosting a parliamentary event on COVID-19 and future pandemic preparedness. We also engaged with other civil society groups including the People’s Vaccine Alliance, G2H2 and the GFAN PPR Advocacy Working Group. To commemorate the anniversary of COVID19 being declared a pandemic, we produced a video with a patient leader and Baroness Shami Chakrabarti for social media that highlighted the lessons learned and the need for the UK Government to support equitable access in the Pandemic Treaty. This reached a total of over 2,500 views.

In late 2022 we commissioned separate research reports to investigate the relationship between the UK Government and European Commission and the pharmaceutical industry, and how this impacted global equitable access to COVID-19 health technologies. In Spring of 2023 we launched four reports in the ‘Access Denied’ series. Two of these reports were focused on COVID19 in the European Union, in collaboration with Global Health Advocates. These reports were launched at an online webinar with over 70 attendees. There has been strong engagement through social media campaigning and in broader media following the launch of the reports. This includes stories about the reports in Euractiv, Euro News, Yahoo News, APM Health Europe and the Politico Healthcare newsletter.

In line with our report’s recommendations, we were also pleased that the COVI Committee report made recommendations related to enhancing transparency regarding price, public vaccine funding and procurement and the real costs of R&D, and the Commission proposed to create an EUwide compulsory licensing instrument in crisis situations that have an EU-wide impact.

In addition, to build parliamentary awareness and support, we hosted an inperson parliamentary events to launch the UK reports. We were pleased with the strong attendance, positive response and interest from stakeholders in wanting to support taking forward the report recommendations. This has included us subsequently arranging meetings with cross-party parliamentarians and senior civil servants from the UK’s Department for Health & Social Care; Department for Business and Trade; and the Foreign, Commonwealth and Development Office. We have also used the findings from the reports to feed into policy processes including submissions to the Labour Policy Forum and a UK Government Science and Technology Committee Inquiry into ‘Emerging diseases and learning from COVID-19’.

Meaningful civil society involvement in design, implementation and governance of digital technologies and AI in health.

STOPAIDS is the global advocacy and youth mobilisation lead for the Digital Health and Rights Project (DHRP) consortium, which we co-founded in 2019 alongside the Global Network of People living with HIV (GNP+), the Kenya Legal & Ethical Issues Network on HIV and AIDS (KELIN) and the Global Health Centre at the Graduate Institute.

In the summer of 2022 STOPAIDS ran an international campaign action ‘Leave no young person behind in the digital age’ with

GNP+, Y+ Global, Restless Development, Y- ACT, YET4H and Masquetresletras. Over 315 people took the e-action online, with significant numbers taking action from Kenya, Ghana, Colombia, and the UK. The e- action called on the WHO and Member States to prioritise young people’s digital health rights and was available in 4 languages, along with a campaign briefing and social media graphics. The DHRP also successfully secured two conference sessions at RightsCon in June, reaching a total of 72 participants, and STOPAIDS coled one session with our youth partners and spoke on a separate panel, enabling us to both improve young participants’ knowledge of digital health and rights and promote emerging learnings and recommendations from ongoing research in Vietnam, Kenya and Ghana.

In the autumn of 2022, STOPAIDS held two consultation workshops, one with 15 young people and another with 19 civil society organisations, with co-hosts Privacy International. With input from the workshops and additional input through surveys, STOPAIDS coordinated the development of two joint submissions for the UN Special Rapporteur (UNSR) on the right to health’s upcoming report on ‘Digital technologies, innovation and the right to health’. As a result, we increased the participation of young people and civil society in shaping digital health governance.

In November, the Digital Health and Rights Project (DHRP) launched its new joint research report into young people’s experiences of digital health technologies from Vietnam, Ghana and Bangladesh. We subsequently presented the recommendations from this report to the Global Fund staff in early 2023.

Clear principles drive the private sector’s role in health to reduce inequality and deliver global health goals

In 2022 we continued to work with civil society colleagues and parliamentarians to hold them accountable on their investments into for-profit healthcare and explore how they could improve this approach. This included communication with IDC Chair, Sarah Champion MP, and other IDC members ahead of the IDC session with senior officials from the British International Investment (BII) and the FCDO. We also continued to advocate on the Global Fund and other INGO’s approach to private sector engagement. This includes playing an active role in the Consortium Against Healthcare Commercialisation. STOPAIDS coorganised a webinar as part of the World Bank Civil Society Policy Forum 2022, entitled ‘The Bank’s Investments in Private Healthcare Provision: What implications for the right to health?’. During the webinar we presented on the principles for ODA funded private sector engagement.

A key moment for this work in 2022 was the official launch of these Principles for ODA-funded Private Sector Engagement in Global Health' in November. In collaboration with the Kampala Initiative PPP Working Group, we co-hosted a webinar to launch the principles. The discussion highlighted cross-sector casestudies and explored how the principles could be applied to help realise the right to health. Following the webinar, we were pleased that several civil society and community led organisations endorsed the principles and expressed interest in further collaboration on this area. A target for our advocacy in this area, the Global Fund’s Head of Private Sector Engagement, also spoke on the webinar.

Ensuring Enhanced Quality of Life for people living with and affected by HIV

Enhanced funding for and access to quality HIV prevention, treatment, care and support

Throughout 2022 we focused on our replenishment strategy to build and mobilise parliamentary support for the Global Fund to Fight AIDS, Tuberculosis and Malaria. This included developing several parliamentary briefings linking investment into the Global Fund into key UK priorities, having 1:1 meetings with parliamentarians, mobilising constituent campaigners and organising several parliamentary events. These events included a reception to mark the International Day Against Homophobia, Biphobia and Transphobia where we had a representative from the Global Fund and a Kenyan LGBT+ human rights defender working on a Global Fund project speak; a cross-working group campaigner parliamentary Day of Action which created opportunities for MPs to meet their constituents and discuss the Global Fund; and STOPAIDS supported a high-level parliamentary reception in June 2022.

Human rights defender Idris Mwendwa speaking at our parliamentary reception on IDAHOBIT

We also focused on mobilising public support for the Global Fund. Through the STOPAIDS-chaired Campaigns Taskforce, we worked collaboratively with ONE to support an online action whereby UK citizens could write messages to their MPs on why they support the Global Fund. We also organised a Day of Action where grassroots campaigners from across our UK network came together for a training, photo stunt and MP drop-in event in Parliament. The lobby day reached over 25 MPs in person at the lobby day and sent the personalised booklets to all 650 MPs.

In November, Andrew Mitchell announced a UK pledge of £1 billion to The Global Fund. Whilst this the fourth largest pledge for the seventh replenishment, it represented an almost 30% cut from the UK’s 2019 pledge. Although was there was strong political support for the Global Fund from FCDO ministers and civil servants, the pledge was fundamentally constrained by the reduction of ODA from 0.7% to 0.5% of GNI, by the reduction of overall multilateral share compared to bilateral, and by the dramatic reduction of funds available for the FCDO compared to other departments. FCDO staff and Minister Mitchell himself credited our campaign with providing the key pressure necessary to boost the end pledge from 800 million to 1 bn.

Looking forward the UK government is highly unlikely to unlock additional resources to the Global Fund or other agencies without a return to the 0.7% spending commitment and ensuring ODA spent domestically to support in-country refugee costs is taken from a different budget. STOPAIDS has therefore sought to build parliamentary support for UK leadership in global health and align the Global Fund as playing a critical role in delivering the UK’s strategic objectives at scale.

Navendu Mishra MP at Conservative Party Conference 2022

In 2022 we also advocated for increased funding support for UNITAID. We worked to build the visibility of Unitaid amongst UK parliamentarians and UK civil society. In June, STOPAIDS hosted a UK parliamentary reception in London to coincide with Unitaid’s 15th anniversary. The event was attended by a diverse group of key stakeholders from Unitaid’s UK partners, UK civil society, the FCDO, Unitaid’s Executive Director, Head of External relations and Head of

Communications as well as various parliamentarians including Lord Cashman, Lord Cunningham, Lord Collins and Baroness Barker. The event highlighted the impact of UK Aid investments into Unitaid and strengthened parliamentary support to mobilise resources for Unitaid.

STOPAIDS held an event at the Conservative Party Conference, where various Conservative MPs, including Andrew Mitchell, spoke on the importance of multilaterals like Unitaid and the Global Fund. Through ongoing engagement with parliamentarians (through briefings, meetings and targeted questions), FCDO officials and the media (through opeds) on the importance of continued commitment to Unitaid, this work area has contributed to the UK’s confirmed funding commitment to Unitaid for this year of 14 million.

Andrew Mitchell MP at Conservative Party Conference 2022

Meaningful integration of HIV with and access to broader physical and mental health issues / UHC

Throughout 2022 we continued to work with the Quality of life partnership, focusing on key advocacy opportunities including AIDS2022. We coordinated planning meetings within the partnership to ensure that the concept of quality of life was promoted throughout the conference and we had a unified message across all the partnership's events. During the conference we hosted an event titled Making the Fourth 90 a priority in HIV policy and clinical care: A roundtable of policymakers and HIV clinicians. In this event, we promoted the concept of quality of life and discussed how our organisation focuses on quality of life as a key advocacy area.

In October STOPAIDS submitted evidence to the APPG on HIV & Aids Quality of Life

Inquiry. We gathered evidence from across the quality-of-life partnership and ensured that the perspective of community organisations and marginalised groups was included in our submission. In December STOPAIDS collaborated with Prevention Access Campaign (PAC) to run a campaign on World Aids Day. The campaign raised awareness among civil society and th public about the link between QoL and U=U, and how QoL and U=U are a holistic and whole-life course approach to achieving global HIV targets.

Reduction of HIV-related structural barriers

We collaborated with the APPG on HIV; APPG on LGBT+ Rights for a parliamentary reception to mark the International Day Against Homophobia, Transphobia and Biphobia. Working with Idris Mwendwa from the HIV & People’s Alliance of Kenya and trans activist Rebecca De Havilland, the event platformed first-hand testimony about the impact of the inequality of access to healthcare that LGBT+ communities face; the impact of criminalisation; and the importance of community led interventions to improve the HIV response.

Lord Herbert (The UK Govt's LGBT envoy) and Lyn Brown (The Shadow Africa Minister) spoke at the reception on issues regarding the UK’s funding to the Global Fund, UNAIDS and further action it can take to advance global LGBT+ rights following the cancellation of the Safe To Be Me Conference. The event reached around 10 parliamentarians; and key civil society partners; with it contributing to additional actions from parliamentarians and helping to highlight how increased investments to the Global Fund will deliver on the UK’s commitments to leave no one behind.

Transforming aid, solidarity and development Co-operation

Global development concepts & structures transformed to deliver for the post-2030 agenda In 2022 STOPAIDS became a founding member of the Global Public Investment network (GPIN).Throughout 2022 and into early 2023, we worked on global governance and meaningful participation which supports the ‘All Decide’ principle. At the international level we promoted the Global Public Investment (GPI) principles with C7 Health Equality working group.

For World AIDS Day we hosted a meeting in parliament around the WAD theme Equalise with LCID and Labour parliamentarians and our Director spoke on Global Public Investment and how Labour’s international development work should be structured around the concept. In December STOPAIDS also co-hosted a parliamentary event in the house of commons with Action for Humanity and other organisations. This event was aimed at highlighting the need to rethink international development and had Preet Gill Shadow Cabinet Minister for International Development and Charalambous the Shadow Minister for the Middle East and North Africa as speakers. STOPAIDS ensured that GPI messaging was included in the brief of this event that was sent to all MPs and guests of the event. Additionally, we also authored a piece for BOND that demonstrated how GPI is the key to ending the inequalities in the HIV response and tackling the social and structural determinants of public health on a global level. It was posted on the BOND website on World Aids Day.

Meaningful civil society and community involvement in global health governance/ Pandemic Preparedness and Response

STOPAIDS has been focusing its global advocacy on GPI in two directions – The Pandemic Fund and the Pandemic Accord. We led global advocacy for and ran the open selection process to identify 48 civil society and community representatives within the Access to Covid Technologies –Accelerator (ACT-A) and built a support platform with GFAN and Waci Health to support meaningful engagement of representatives throughout the pandemic. This ensured that every aspect of ACT-A had reserved space for communities and civil society to bring their expertise, experience and voices to the table and influence global decision-making to better serve the needs of those most affected by Covid.

We also led global advocacy to make the case for and successfully secure two civil society voting seats at the newly established Pandemic Fund (when originally there were no seats for civil society included). We led the open selection process to identify both interim and permanent Board Members for the Global North Constituency and led work with others to establish a civil society constituency to support the global south and global north Board members.

Anti-Oppression Framework

Our anti-oppression framework is a new and significant undertaking for us as an organisation and has had a huge impact on how we work and how we hold ourselves and others to account. The framework is primarily centered around challenging and reversing problematic practices or oppressive logics that need to be undone and promoting anti-oppressive values. The five key values of the framework are: Humility, ways of working that show self-restraint but also ask you to reflect on your positionality, the power dynamics involved, and the value of / need for your contribution in an activity or setting; Shifting Power, ways of working that seek to halt exploitative practices and address the cumulative disadvantages that exploitation has left behind by redistributing power; Solidarity, ways of working that ask you to take as many opportunities as possible to ‘spend’ your social capital or use your position/resources to challenge stigmas and the continued demonisation of certain people/groups; Co-ownership, ways of working that don’t presume the superiority of your approach and instead create opportunities to benefit from missing insights and skills by engaging in collective work; and the meaningful engagement of people living with and affected by HIV and other health conditions, ways of working that ensure that the voice and perspectives of those with lived experiences informs every aspect of what we do.

We worked with these partners to identify key principles and guiding questions, analyse the potential opportunities, responsibilities and risks of our implementation of the framework, and identify a set of ideal behaviours and actions or ‘experiments’ to move us towards these ideals. Over the last 12 months we undertook experiments in each operational area to explore how to turn these ideas into practices, helping to embed the framework’s values into our everyday work. As we move forward into 2023-24, we will work to ensure the successful implementation both internally and externally of our anti-oppression framework and will work to engage with the broader sector on our framework to create a movement through partnerships and call for sector-wide change.

Media Coverage

In the face of a challenging media landscape, STOPAIDS media work has played a crucial part in both the Global Fund Replenishment Campaign and through our Missing Medicines Coalition, but also more widely on the issue of international development, the ODA budget, and HIV awareness. Through our Chairing of the Global Fund Replenishment Working Group the Campaigns and Media Officer has chaired a regular Campaigns Sub-Working Group and another Sub-Working Group on Communications and Media, with both of these working to develop interventions and coordinate with our members to maximise coverage – this includes sharing of information, coordination of pitching stories, and developing news angles for stories, opinion pieces and more.

From April 2022 to March 2023 STOPAIDS secured 57 media pieces in leading UK and international outlets, 6 were op-eds and the rest were coverage of advocacy interventions, reactions, or broadcast interviews. Additional coverage has been achieved in outlet newsletters or other minor outlets that report from newswires; we do not have sophisticated media analytics as this would be an additional subscription cost.

Highlights from the work of the Global Fund Replenishment Campaign:

·In June, 15 former Heads of Government of Commonwealth Nations, including David Cameron and Gordon Brown called on the UK and all Commonwealth donors to increase pledges in an open letter which we coordinated with the ONE campaign. This was covered in The Independent.

At a similar time, with the Conservative Party Leadership election underway, we worked with UNAIDS on an op-ed from Lord Fowler and Winnie Byanyima arguing for the next UK PM to refocus global efforts to end AIDS, which ran in The Times (Red Box).

On the day Liz Truss was elected Conservative leader and became PM, the Campaigns and Media Officer carried out a stunt in Truss’ constituency with support Aid Alliance members that included a giant clock to say ‘Every Minute Counts’ in the fights against AIDS, TB and malaria. The stunt was strategically located for media interest and subsequent broadcast coverage ran in BBC Look East, ITV East Anglia, and coverage featured in BBC Online

In September, when the replenishment conference occurred but the UK did not pledge, we secured a reaction in The Telegraph (and later in October ran an op-ed from Lord Fowler and Lady Roslyn Moruta in the same outlet).

·As the deadline for the UK to pledge approached, we briefed journalists on developments and got the Independent to run a story in early November. Prior to the pledge we put out an op-ed in The Telegraph from Conservative Chair of the Health and Social Care Committee Steve Brine MP that argued the UK risked stepping off the world stage if it didn’t make a strong pledge.

·In mid-November our reaction to the UK’s pledge was highly effective in shaping UK and global coverage – with the Director frequently the leading civil society quote, and framing and statistics from our reaction used in coverage; see The Guardian, The Telegraph, Reuters, The Daily Mail, Al Arabiya.

·The Director was also interviewed by The New York Times for their coverage of the UK pledge.

·The UK pledge was also put into perspective compared to G7 allies including Italy, when the Director spoke to Sky News Italy for a broadcast feature for World AIDS Day, unfortunately – the footage was not picked up for use by Sky News in the UK.

Highlights from the work of the Missing Medicines Coalition:

In April, the MMC protested Pfizer’s pandemic profiteering as their quarterly profits were announced, securing coverage in The Guardian and other outlets, including the BMJ’s big photo feature.
In June when the TRIPS waiver decision was reached, the coalition denounced the UK’s move to block the waiver – driving a story in The Independent.

When a leaked chapter of the UK-India Free Trade Agreement revealed in November that UK proposals would harm the Indian generics industry and threaten NHS drug prices and global access to medicines, we put out a letter to the Trade Secretary with our concerns. Initial coverage in City AM developed to further stories over time in the Mirror (including another intervention with Indian health groups), The Times of India, The Indian Telegraph, and broadcast coverage on LBC News where the Global Justice Now Director was interviewed.

o All of this repeatedly forced the Trade Secretary to go on record that no deal would include proposals that harm the NHS.

At the time of writing and following further advocacy, we understand these proposals will be dropped from the final deal.Overall, our op-eds have struck a balance between coming from Conservative and Labour voices, with other voices from civil society, communities and smaller parties such as the Liberal Democrats being featured.

We continue to strive to better platform voices from affected communities and continue to co-create interventions wherever possible with partners in low- and middle-income countries.

Membership Engagement

The aim of our membership engagement work is to ensure the growth and sustainability of our membership network and share knowledge and best practice to further our common goals. This includes ensuring diverse and relevant opportunities so that a broad range of members can engage and collaborate on activities to further our common goals and objectives.

Member meetings are a key opportunity for members to engage with the network on different thematic topics. In December 2022 we held our AGM which focused on role of the HIV response in pandemic prevention, preparedness, and response (PPR) and Universal Health Coverage (UHC). The purpose of the meeting was to bring members together to discuss how HIV, PPR and UHC intersect, and how to work together on the 2023 High-Level Meetings and other relevant processes/institutions. At the meeting we also presented a draft of our factsheet which focused on how HIV, PPR and UHC fit together and made the case for the prioritisation of the HIV response in PPR & UHC. Several members presented on the work that they were doing on PPR including positioning the HIV response in the PPR architecture, the importance of community engagement in the PPR response and the intersection between GPI and PPR.
In early 2023 we also convened members for a meeting on the shorter working week (which STOPAIDS formally implemented in April 2021 following an 18-month pilot) as part of our member sharing sessions which are designed to focus on issues that sit outside our core advocacy topics. There was a presentation from the 4 Day Week Campaign as well as the STOPAIDS team who spoke to how and why we implemented the shorter working week as well as how we tracked and monitored the impact of the SWW of our work and working lives.

We are delighted that we continue to see high levels of engagement from our members at these meetings, which are designed to be collaborative, interactive and helpful.

----- Start of picture text -----
Youth STOP AIDS campaigners at Pride 2022
----- End of picture text -----

Hosting role

As a member-based convening network, STOPAIDS knows the value of support and facilitation, particularly for smaller organisations. Our contributions to global health and the HIV response are not just evidenced through our advocacy efforts but also our organisational structure.

STOPAIDS supports organisations/ groups in the global public health space to achieve their goals by hosting their staff and/or providing governance, financial administration and project support services. This back-office support gives the institutional framework necessary for smaller organisations to exist and work without registering as separate legal entities- which is not always possible for smaller organisations from a capacity and resource standpoint.

STOPAIDS currently hosts or supports:

Action For Global Health: a UK advocacy network of 4 staff with 55 member organisations focused on global health. We hold their funding and employ the staff.
Students For Global Health: a network of global health student campaigners in the UK. We hold their funding and employ the Coordinator who has line management from Action for Global Health.
All Party Parliamentary Group (APPG) on HIV & AIDS: we employ the Coordinator and provide them with an annual grant.
Youth Stop AIDS: a network of 300 youth campaigners: we financially support and provide guidance to and matrix manage the Coordinator.
UNITAID Board NGO Delegation: we hold the delegation grant and employ the UNITAID NGO Delegation communication focal point.
Global Network of People Living with HIV (GNP+): we have an MoU with GNP+ to employ 2 members of their staff based in the UK
Global Fund to fight AIDS, TB and Malaria: we hold the grant for Strategy Committee Leadership support and employ the Advisor.
Platform for ACT-A Civil Society and Community Representatives: We are
a co- lead of the Platform alongside GFAN and WACI Health (the latter of which is the fiscal host). We also employ the Platform Co-ordinator.

Youth STOP AIDS campaigners at Pride 2022

Plans for 2023-24

People Over Profit

In 2023 we will continue to focus on the TRIPS waiver for COVID-19 vaccines and build our relationship with civil servants in the Department for International Trade. On our PPR work we will work to influence the outcome of the Pandemic Accord. We will also promote and disseminate our Access Denied reports which are now a firm part of our evidence base and will support our advocacy for a fairer medical R&D and fairer pharmaceutical system.

STOPAIDS will continue to be the advocacy lead in the Digital Health and Rights Project (DHRP) and will convene and support DHRP to raise awareness about digital rights and influence human rights mechanisms, global health agencies and governments to address these. In 2023 and 2024 we will organise multiple youth and civil society workshops, including at RightsCon 2023 and the Students for Global Health conference. We will develop policy on the issue, including for the 3 UN High-Level Meetings addressing health this year, the Global Digital Compact and the UN Special Rapporteur on the Right for Health (UNSR), and advocate among the Global Fund governance bodies for increased attention to digital health and rights.

Ensuring Enhanced Quality of Life for people living with and affected by HIV

On our work to enhance to and funding for HIV services, over the course of 2023 and 2024 we will focus on building parliamentary and UK government support and increased resources for key institutions: the Global Fund, UNITAID, UNAIDS and Robert Carr Fund. There will be a particular focus on the Robert Carr Fund which has its replenishment in the summer of 2024.

On our work around the meaningful integration of HIV with and access to broader physical and mental health issues / UHC we will focus on building advocacy through the development of briefings for the HLMs on UHC and PPR and TB, - promoting key HIV issues and learnings and anti-oppressive approaches into the realisation of PPPR and UHC.

On our work to reduce HIV-related structural barriers we will continue to be active on the global solidarity response to the Anti-Homosexuality Act in Uganda and its impact on the HIV response, as well as the wider rollback of LGBTQ+ rights globally.

STOPAIDS and partners protesting against Uganda’s anti-homosexuality bill

Transforming aid, solidarity and development co-operation

As the ACT-A draws to a close in March 2023, we will continue to work with GFAN and WACI Health through the Platform for Civil Society and Community Representatives to bring the lessons of ACT-A and engage in broader PPPR and global health processes to ensure meaningful involvement of civil society and communities. We will do this through advocating for the formal inclusion of civil society and communities in governance bodies and in relevant processes such as the Pandemic Fund, the Pandemic Accord, the MCM Platform, the Future of Global Health Initiatives process and existing global health institutions. Then, once representation is secured, we will support the open transparent selection of diverse civil society representation that is supported to be representative and accountable. We will continue to bring together the civil society and community representatives of global health institution Boards together quarterly to share intelligence and develop shared strategies. We will also work with them to develop and finalise the Principles for the Meaningful Involvement of Civil Society and Communities which will establish global norms for good practice.

Throughout 2023 we will further advocate for Global Public Investment and the core principles of ‘All Contribute, All Decide, and All benefit’ at the global level and within the UK. At the global level we will get further involved in the Global Public Investment Network and co-ordinate civil society advocacy for GPI across PPPR and global health institutions. In the UK we will further engage the UK Government, parliamentarians (particularly Labour) and civil servants to build awareness and support for the GPI principles and the broader shift towards some fundamental reforms to the UK approach to development co-operation.

----- Start of picture text -----
Pandemic Treaty Webinar on Meaningful Involvement of Civil Society and Communities
----- End of picture text -----

STOPAIDS Team

Mike Podmore Director

Tabitha Ha Strategic Adviser to the Global Fund’s Strategy Committee Leadership, Strategic Advisor Digital Health

Olivia Compton Communications and Community Engagement Officer

Siomha Cunniffe Development and Network Manager

Nicole Woods Senior Finance Officer

Vivienne Price, Team Coordinator

Jake Atkinson Campaigns and Media Officer

Nabila Saddiq Tayub Policy & Operations Project Manager

James Cole, Advocacy Advisor/Advocacy Manager (Maternity cover)

Molly Pugh Jones, COVID-19 Advocacy Officer

Amina Babirye Advocacy

Saoirse Fitzpatrick Advocacy Manager

Courtenay Howe Platform Coordinator (Platform for ACT-A Civil Society and Community Representatives)/ Senior Advocacy Advisor (STOPAIDS)

Molly Thompson, NGO Delegation Liaison Officer (UNITAID Board) / Advocacy Officer (STOPAIDS)

Structure, governance and management

TRUSTEES

Yael Azgad, Avert Tricia Cassidy, mothers2mothers Romilly Greenhill, ONE

Husseina Hamza, Africa Advocacy Foundation

Vicki Howard (Treasurer), Marie Stopes International Fionnuala Murphy (interim Chair), Frontline AIDS

Georgie Wallis, Youth Stop AIDS

STOPAIDS is a company limited by guarantee, registered in England no. 2589198, and is UK registered charity No. 1113204.

REGISTERED OFFICE:

167-169 Great Portland St, London W1W 5PF, United Kingdom

AUDITORS

Wenn Townsend, 30 St Giles, Oxford OX1 3LE

PRINCIPAL OFFICERS

Michael Podmore (Executive Director) Siomha Cunniffe (Development and Network Manager)

BANKERS

THE CO-OPERATIVE BANK PO Box 101, 1 Balloon Street, Manchester M60 4EP

The directors of the charitable company are its trustees for the purpose of charity law and the members of the company limited by guarantee. Throughout this report they are collectively referred to as the Trustees or the Board of Trustees.

All trustees served for the full year unless otherwise indicated above. None had any beneficial interest in the charity and no remuneration of trustees/ directors is paid by the charity.

The trustees are pleased to present their report together with the audited financial statements of the charity for the year ended 31 March 2023.

Governing Document

STOPAIDS is a charitable company limited by guarantee, incorporated on 6 March 1991 and registered as a charity on 19 March 2006, it changed its name from The UK Consortium on AIDS and International Development on 5th September 2013. The company was established under a Memorandum of Association which established the objectives and powers of the charitable company and is governed under its Articles of Association. These Articles were updated by members on 22nd January 2014.

Organisational Structure

The Board of Trustees can have up to 12 members. It meets every three months and is responsible for the strategic direction, policy and overall governance of the charity. Members of the Board of Trustees, 10 members of which must be nominated from Member Organisations of STOPAIDS and two of which must be living with HIV, are elected to serve for a period of two years. They may stand for re-election once, serving for a maximum of four years, after which they must stand down for at least one year. Once a Trustee has been elected to the Board, they meet with the Board Chair, the Director and the Development and Network Manager for an induction session. They are also introduced to the team and provided with an overview of each team member's role. As part of the induction new Trustees are provided with a term of reference outlining the role, main responsibilities and tasks of the board and details about appointment and eligibility of board members, term of office, meetings and expectations of Trustees. Trustees are required to review and sign the Trustee Terms of Reference. They are also provided with the following documents: The Charity Commission's Essential Trustee Guide, STOPAIDS's governing documents, the most recent annual report and accounts, the organisational strategy, an organisational chart and an overview of the board subcommittees.

Trustees operate three sub-committees: Fundraising and Membership, Finance and HR. A minimum of 3 trustees sit on each sub-committee.

Day to day running and management, including financial management of STOPAIDS office and activities is the responsibility of the Secretariat, led by the Executive Director. STOPAIDS also works in close collaboration with Youth Stop AIDS and is committed to supporting the development of youth leadership in the global HIV response and therefore has one place on the Board for a representative of the Youth Stop AIDS network.

The Directors who held office during the year are listed under reference and administrative details above.

Key Management Personnel Remuneration

The Trustees consider the Board of Trustees, the Director and the senior leadership team as comprising the key management personnel of the charity in charge of directing and controlling the charity and running and operating the charity on a day to day basis. All Trustees give of their time freely and no Trustee remuneration was paid in the year.Details of Trustee expenses and related party transactions are disclosed in note 4 to the accounts.

Trustees are required to disclose all relevant interests and in accordance with the Trust’s policy withdraw from decisions where a conflict of interest arises.

The pay of the Director and senior leadership team is reviewed annually and is normally increased in line with our pay policy. The remuneration is reviewed to ensure that it is commensurate with similar roles.

Risk Management

The Trustees review the risks the charity faces at every Trustee meeting. The Risk Log for the organization continued to assess the low, medium and high risks posed to the organisation and ensured discussion at the Board of priority actions to mitigate high risks. During the year risk management focused heavily on the Covid-19 pandemicparticularly it's impact on STOPAIDS staff and member organisations, key at risk and marginalised populations within the UK and globally and the delivery of the STOPAIDS Strategic Plan. We also focused on cuts in funding and resource mobilisation for the HIV sector and the international development/ global public health sector generally due to the global cost of the pandemic. Foremost in these discussions was the UK government’s decision to cut foreign aid funding from 0.7% to 0.5% of gross national income. We also acknowledged that there has been a further shift in focus away from HIV by many generalist NGOs, as well as the UK Government.

Fundraising standards information

Members of the Charity’s fundraising department organise events and carry out fundraising activities to generate funds for the charity. The Charity does not use professional fundraisers or commercial participators. There have been no complaints about fundraising activity this year. The charity has signed up to the Fundraising Regulator’s Code of Fundraising Practice.

All the charity’s marketing activities are undertaken directly to ensure that it is not unreasonably persistent or intrusive. Direct marketing materials contain clear details of how to unsubscribe to future communications and care is taken to limit the level of communications being sent out.

OBJECTIVES AND ACTIVITIES

THE RELIEF OF SICKNESS, AND THE PRESERVATION AND PROTECTION OF GOOD HEALTH OF PEOPLE LIVING WITH HIV AND AIDS OR AT RISK OF HIV TRANSMISSION IN DEVELOPING COUNTRIES BY, IN PARTICULAR BUT NOT EXCLUSIVELY:

PROVIDING A FORUM FOR THE EXCHANGE OF INFORMATION AMONG AND BETWEEN NON-GOVERNMENTAL BODIES
LIAISING WITH GOVERNMENTAL AND INTERNATIONAL BODIES; AND
EDUCATION OF THE PUBLIC ON HIV AND AIDS AND THE WORK OF NON-GOVERNMENTAL BODIES IN THE FIELD.

Public Benefit Statement:

Trustees have referred to the guidance contained in the Charity Commission’s general guidance on public benefit when reviewing aims and objectives and planning future activities. Our direct beneficiaries of STOPAIDS are our member organisations and the organisations and groups that we host. However, the ultimate beneficiaries of all of our work are global population of people living with and affected by HIV and AIDS who are supported by our members and by the domestic and international STOPAIDS advocacy efforts and the technical support and advice we provide to the UK government and multilaterals on their role in the global HIV and broader global health inequity response.

Financial review

The Trustees are pleased with the financial performance this year, particularly considering the substantial economic challenges that the organisation has faced, including a cost-of-living crisis and inflation, and its impact to our funding streams. We have worked hard and continued strong relationships with funders and secured new sources of income whilst maintaining the backing and trust of our members, without who's financial and time contributions, STOPAIDS would not thrive as a convening and advocating network.

STOPAIDS has continued to expand its role of hosting staff from other organisations working to similar objectives as STOPAIDS. This allows us to facilitate and support their work by managing employment contracts and back end financial and administrative office support at an overhead fee of 10-15% of the costs involved. As well as providing an essential service to other organisations without the capacity to function as separate legal entities, this allows economies of scale to further the efficiency of our operations.

Income for this period was £1,209,283 (£1,150,745 in 2022). This includes restricted funds from grant making trusts of £996,080 (compared to £682,066 in 2022). Monies from membership fees accounted for 10% of total income (8.5% the previous year). Total expenditure for this period was £1,377,698 (£927,619 in 2022). Our income and expenditure increased this year due to a couple of factors; the securing of a few multi-year core grants, the expansion of the STOPAIDS team and the continued growth of Action for Global Health whom we host. There was a deficit for the year of £168,415 (surplus of £223,126 in 2022), giving total funds of £480,329, of which £251,932 is unrestricted and £228,397 is restricted.

At the end of the year the charity remains in a healthy financial position and the trustees consider this to be a very pleasing result, particularly in light of funding cuts experienced by many member organisations. It was a strong vote of support that members demonstrated their continued commitment to STOPAIDS through continued payment of membership fees. The charity will continue to closely review financial performance on a regular basis to ensure actual income and expenditure is in line with budget. There will be particular focus on income generation and diversifying sources of income in order to maintain this healthy position.

Reserves

It is the policy of STOPAIDS to maintain a reserves level to ensure delivery of core goals in line with the STOPAIDS Strategy. The trustees wish to ensure adequate reserves to mitigate any risks. Our general reserves fund policy is a minimum of 3 and up to 9 months operating costs. Maintaining reserves at this level will ensure resilience against foreign exchange fluctuations, changes in membership funding and any other unanticipated impact of political changes and ensure that STOPAIDS can meet its legal obligations as an employer should be we cease to be a going concern/ experience a significant adverse event to our funding stream. The trustees review the policy against the Risk Register on a regular basis.

During the year our reserves, shown on the balance sheet as unrestricted funds have decreased to £251,932 (£401,481 in 2022), which are within the desired range as detailed above.

Statement of Trustees Responsibilities

The Trustees (who are also directors of STOPAIDS the purposes of company law) are responsible for preparing the Trustees’ Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice). Company law requires the Trustees to prepare financial statements for each financial year, which give a true and fair view of the state of affairs of the charitable company and of the incoming resources and application of resources, including the income and expenditure, of the charitable company for the year. In preparing these financial statements, the Trustees are required to:

select suitable accounting policies and then apply them consistently; observe the methods and principles in the Charities SORP 2019 (FRS 102); make judgements and estimates that are reasonable and prudent;
state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements;
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the charitable company will continue in operation.

The Trustees are responsible for keeping adequate accounting records that disclose with reasonable accuracy at any time the financial position of the charitable company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

there is no relevant audit information of which the charitable company’s auditor is unaware; and the Trustees have taken all steps that they ought to have taken to make themselves aware of any relevant audit information and to establish that the auditor is aware of that information.
The Trustees are responsible for the maintenance and integrity of the corporate and financial information included on the charitable company’s website. Legislation in the United Kingdom governing the preparation and dissemination of financial statements may differ from legislation in other jurisdictions.

This report has been prepared having taken advantage of the small companies’ exemption in the Companies Act 2006.

The accounts were approved at a meeting of the Trustees on 14th September 2023 and signed by:

Trustee : Treasurer, Vicki Howard

Independent Auditor ’s Report to the members of STOPAIDS

Opinion

We have audited the financial statements of STOPAIDS (the ‘charitable company’) for the year ended 3 1 March 2023 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

give a true and fair view of the state of the charitable company’s affairs as at 31st March 202 3, and of its incoming resources and application of resources, including its income and expenditure, for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfi lled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees’ use of the going concern basis of accounting in th e preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The trustees are responsible for the other information. The other information comprises the information included in the trus tees’ annual report, other than the financial statements and our auditor’s report thereon. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

the information given in the trustees’ report (incorporating the directors’ report) for the financial year for which the fina ncial statements are prepared is consistent with the financial statements; and
the directors’ report has been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the directors’ report.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
the financial statements are not in agreement with the accounting records and returns; or
• certain disclosures of directors’ remuneration specified by law are not made; or

Independent Auditors’ Report to the members of STOPAIDS (continued)

Matters on which we are required to report by exception (continued)

we have not received all the information and explanations we require for our audit; or
the trustees were not entitled to prepare the financial statements in accordance with the small companies’ regime and take advantage of the small companies’ exemptions in preparing the directors’ report and from the requirement to prepare a strategic report.

Responsibilities of trustees

As explained more fully in the trustees’ responsibilities statement set out on page 29, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continu e as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud is detailed below:

Enquiry of management, those charged with governance and the entity’s solicitors around actual and potential litigation and claims;
Reviewing minutes of meetings of those charged with governance;
Reviewing financial statement disclosures and testing to supporting documentation to assess compliance with applicable laws and regulations;
Performing audit work over the risk of management override of controls, including testing of journal entries and other adjustments for appropriateness, evaluating the business rationale of significant transactions outside the normal course of business and reviewing accounting estimates for bias.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditor’s report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company’s members as a body, for our audit work, for this report, or for the opinions we have formed.

...........................................

Benjamin Hayes BSc FCA (Senior Statutory Auditor) For and on behalf of Wenn Townsend Chartered Accountants and Statutory Auditor 30 St Giles Oxford OX1 3LE

14th September 2023

STOPAIDS

Statement of Financial Activities (including Income and Expenditure Account) for the year ended 31 March 2023

----- Start of picture text -----
||||||| |---|---|---|---|---|---| |2023|2023|2023|2022| |Notes|Unrestricted|Restricted|Total|Total| |£|£|£|£| |Income| |Contributions from members and observers|23,550|96,905|120,455|97,571| |Grants and contracts|3a|68,674|996,080|1,064,754|1,051,536| |Donations received|637|-|637|-| |Other income|3b|20,502|2,540|23,042|1,500| |Interest income|395|-|395|138| |───────|───────|───────|───────| |Total|113,758|1,095,525|1,209,283|1,150,745| |───────|───────|───────|───────| |Expenditure on:| |Raising funds|159|-|159|-| |Charitable activities|4|267,831|1,109,708|1,377,539|927,619| |───────|───────|───────|───────| |Total|267,990|1,109,708|1,377,698|927,619| |───────|───────|───────|───────| |Net income/(expenditure)|(154,232)|(14,183)|(168,415)|223,126| |───────|───────|───────|───────| |Transfers between funds|11|4,683|(4,683)|-|-| |───────|───────|───────|───────| |Net movement in funds|(149,549)|(18,866)|(168,415)|223,126| |───────|───────|───────|───────| |Reconciliation of funds| |Total funds brought forward|401,481|247,263|648,744|425,618| |───────|───────|───────|───────| |Total funds carried forward|11|251,932|228,397|480,329|648,744| |═══════|═══════|═══════|═══════|

----- End of picture text -----

The Statement of Financial Activities includes all gains and losses recognised in the year.

All incoming resources and resources expended derive from continuing activities.

STOPAIDS

Balance Sheet As at 31 March 2023

		2023	2022
	Notes	£	£
Fixed assets
Tangible fixed assets	7	2,500	3,247
Current assets
Debtors	8	262,382	80,032
Cash at bank and in hand		676,734	1,037,891
		───────	───────
		939,116	1,117,923
		───────	───────
Creditors:amounts falling due within one year	9	(461,287)	(472,426)
		───────	───────
Net current assets		477,829	645,497
		───────	───────
Net assets		480,329	648,744
		───────	───────
Funds
Unrestricted funds		251,932	401,481
Restricted funds		228,397	247,263
		───────	───────
Total funds	11	480,329	648,744
		═══════	═══════

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

The financial statements have been prepared in accordance with provisions applicable to companies subject to the small companies’ regime.

Approved and signed on behalf of the Executive Committee on 14th September 2023

……………………………………. Vicki Howard - Treasurer

STOPAIDS

Statement of Cash Flows for the year ended 31 March 2023

		2023	2022
	Notes	£	£
Cash flow from operating activities	13	(360,038)	473,708
Cash flow from investing activities
Purchase of tangible fixed assets		(1,119)	(2,315)
		───────	───────
Increase in cash and cash equivalents for the year		(361,157)	471,393
Cash and cash equivalents at the beginning of the year		1,037,891	566,498
		───────	───────
Total cash and cash equivalents at the end of the year		676,734	1,037,891
		═══════	═══════

STOPAIDS

Notes to the accounts for the year ended 31 March 2023

1. General information and basis of preparation

STOPAIDS is a charitable company limited by guarantee in England and Wales. In the event of the charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the charity. The address of the registered office is given in the charity information in these financial statements. The nature of the charity’s operations and principal activities are detailed in the Trustees Report.

The charity constitutes a public benefit entity as defined by FRS 102. The financial statements have been prepared in accordance with Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland issued in October 2019, the Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland (FRS 102), the Charities Act 2011, the Companies Act 2006 and UK Generally Accepted Accounting Practice.

2. (a) Basis of accounting

The financial statements are prepared on a going concern basis under the historical cost convention, modified to include certain items at fair value. The financial statements are presented in sterling which is the functional currency of the charity.

The significant accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented unless otherwise stated.

(b) Fund accounting

(i) The unrestricted funds are available for use at the discretion of the trustees in furtherance of the objectives of the charity.
(ii) Designated funds are unrestricted funds earmarked by the Executive Committee for particular purposes.
(iii) Restricted funds are subjected to restrictions on their expenditure imposed by the donor or through the terms of an appeal.

A final review of the allocation of expenditure is performed after a project or contract has been completed, which can give rise to a transfer between funds.

(c) Income

All incoming resources are included in the Statement of Financial Activities (SoFA) when the charity is legally entitled to the income after any performance conditions have been met, the amount can be measured reliably and it is probable that the income will be received.

(i) Income from grants, donations and gifts is included in full in the Statement of Financial Activities when receivable. Grants, where entitlement is not conditional on the delivery of a specific performance by the Charity, are recognised when the charity becomes unconditionally entitled to.
(ii) Donated services and facilities are included at the value to the charity where this can be quantified.
(iii) The value of services provided by volunteers has not been included in these accounts.
(iv) Investment income arises from interest receivable on funds held in interest bearing bank accounts and is included when receivable.
(v) Income from charitable trading activity is accounting for when earned.

(d) Expenditure

Expenditure is recognised once there is a legal or constructive obligation to make a payment to a third party, it is probable that settlement will be required and the amount of the obligation can be measured reliably.

(i) Expenditure on raising funds comprise the costs associated with attracting voluntary income and the costs of trading for fundraising purposes.
(ii) Charitable expenditure comprises those costs incurred by the charity in the delivery of its activities and services for its beneficiaries. It includes both costs that can be allocated directly to such activities and those costs of an indirect nature necessary to support them.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

(d) Expenditure (continued)

(iii) Other expenditure included governance costs, those costs associated with meeting the constitutional and statutory requirements of the charity and include the independent examiner’s fees and costs linked to the strategic management of the charity and support costs.
(iv) All costs are allocated between the expenditure categories of the SOFA on a basis designed to reflect the use of the resource. Costs relating to a particular activity are allocated directly, others are apportioned on an appropriate basis.

Irrecoverable VAT is charged as a cost against the activity for which the expenditure was incurred.

Support costs are those that assist the work of the charity but do not directly represent charitable activities and include office costs, governance costs, administrative payroll costs. They are incurred directly in support of expenditure on the objects of the charity and include project management carried out at Headquarters. Where support costs cannot be directly attributed to particular headings they have been allocated to cost of raising funds and expenditure on charitable activities on a basis consistent with use of the resources. The analysis of these costs is included in note 4.

(e) Fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended.

Depreciation is provided on all tangible fixed assets, at rates calculated to write off the cost, less estimated residual value, of each asset on a systematic basis over its expected useful life, which is typically applied at 33% per annum on the straight line method. Only items costing over £1,000 are capitalised.

(f) Foreign currency

Transactions in foreign currencies are initially recorded in the entity’s functional currency, which is pound sterling, by applying the spot exchange rate on the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the rate of exchange on the balance sheet date. All differences are taken to the Statement of Financial Activities.

(g) Debtors and creditors receivable / payable within one year

Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in expenditure.

(h) Impairment

Assets not measured at fair value are reviewed for any indication that the asset may be impaired at each balance sheet date. If such indication exists, the recoverable amount of the asset, or the asset’s cash generating unit, is estimated and compared to the carrying amount. Where the carrying amount exceeds its recoverable amount, an impairment loss is recognised in profit or loss unless the asset is carried at a revalued amount where the impairment loss is a revaluation decrease.

(i) Leases

Rentals payable and receivable under operating leases are charged to the SoFA on a straight line basis over the period of the lease.

(j) Employee benefits

When employees have rendered service to the charity, short-term employee benefits to which the employees are entitled are recognised at the undiscounted amount expected to be paid in exchange for that service.

The charity operates a defined contribution plan for the benefit of its employees. Contributions are expensed as they become payable.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

(k) Tax

The charity is an exempt charity within the meaning of schedule 3 of the Charities Act 2011 and is considered to pass the tests set out in Paragraph 1 Schedule 6 Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes.

(l) Going concern

The financial statements have been prepared on a going concern basis as the trustees believe that no material uncertainties exist. The trustees have considered the level of funds held and the expected level of income and expenditure for 12 months from authorising these financial statements. The budgeted income and expenditure is sufficient with the level of reserves for the charity to be able to continue as a going concern.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

3a. Income from grants and contracts

----- Start of picture text -----
|||||||||| |---|---|---|---|---|---|---|---|---| |Total|Total| |Core|Hosting|Advocacy|Other|2023|2022| |£|£| |Restricted Grants| |ACT A|-|-|-|-|-|14,102| |Aidsfonds (Love Alliance)|-|-|98,294|-|98,294|-| |APPGA|-|38,450|-|-|38,450|35,917| |Botnar Foundation|-|-|49,064|-|49,064|15,925| |GNP+|-|101,830|-|-|101,830|102,807| |Joseph Rowntree Ch Trust|-|-|92,700|-|92,700|-| |New Venture Fund Phase III|-|-|133,342|-|133,342|123,079| |Restless Development| |(GenEndIt Campaign)|-|-|12,914|-|12,914|-| |The Bill and Melinda| |Gates Foundation|-|-|239,915|-|239,915|230,492| |The Global Fund|–|NVF|-|-|3,743|-|3,743|39,617| |The Wellcome Trust|-|-|-|-|-|49,936| |The Wellcome Trust|-|-|-|2,679|2,679|-| |(Future of GHIS)|-|-|12,914|-|12,914|-| |UNITAID|-|121,297|39,320|-|160,617|37,626| |WACI Health|-|-|62,532|-|62,532|32,565| |───────|───────|───────|───────|───────|───────| |-|261,577|731,824|2,679|996,080|682,066| |═══════|═══════|═══════|═══════|═══════|═══════| |Unrestricted grants| |Open Society Foundation|-|-|-|-|-|283,889| |Other|68,674|-|-|-|68,674|85,581| |───────|───────|───────|───────|───────|───────| |68,674|261,577|731,824|2,679|1,064,754|1,051,536| |═══════|═══════|═══════|═══════|═══════|═══════|

----- End of picture text -----

During the year STOPAIDS received the following grants:

----- Start of picture text -----
|||||||| |---|---|---|---|---|---|---| |Grant|Purpose of Grant| |Aidsfonds (Love Alliance)|Global|advocacy|partner|supporting|the|key| |objectives of the Love Alliance Consortium| |All Party Parliamentary Groups on Aids (APPGA)|Reimbursement of salary for the Policy Advisor of the| |All Party Parliamentary Group on HIV and AIDS| |administered by STOPAIDS| |Botnar Foundation|Digital rights and health project for Botnar Foundation| |Global Network of People Living with HIV (GNP+)|Reimbursement|of|salary|for|Staff|GNP+| |administered by STOPAIDS| |Joseph Rowntree Charitable Trust|Putting public health ahead of profit: Increasing| |transparency|and|public|accountability|within| |pharmaceutical/government relations during the| |COVID19 pandemic| |New Venture Fund|To enable STOPAIDS to engage in high profile| |advocacy in an attempt to increase the UK| |government’s pledge to the Global Fund at the next| |replenishment| |Restless Development (GenEndIt Campaign)|Providing support and research to build young| |leaders capacity to identify national and global trends| |and advocacy opportunities| |The Bill and Melinda Gates Foundation|To support Action for Global Health| |The Wellcome Trust|Strengthening the climate and health capacity of| |AfGH and SfGH| |UNITAID Liaison Officer|To host the Civil Society Liaison Officer post| |WACI Health|To support the coordination of the communities and| |civil society Act A platform|

----- End of picture text -----

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

3b. Other income

3b.	Other income
				Total	Total
		Unrestricted	Restricted	2023	2022
		£	£	£	£
	Hosting fees	10,632	-	10,632	-
	Kickstart government scheme	6,437	-	6,437	-
	Rental income	2,683	-	2,683	-
	Contributions to events/roles	750	2,000	2,750	-
	Miscellaneous	-	540	540	1,500
		───────	───────	───────	───────
		20,502	2,540	23,042	1,500
		═══════	═══════	═══════	═══════
4.	Expenditure

Expenditure
			Total	Total
Unrestricted		Restricted	2023	2022
	£	£	£	£
Charitable activities
Staff costs	274,801	727,886	1,002,687	733,977
Recruitment	1,630	1,500	3,130	8,074
Staff training	3,742	1,787	5,529	3,406
Freelance staff/consultants	20,722	86,516	107,238	53,066
Travel and subsistence	2,656	52,961	55,617	8,897
Marketing and communications	6,043	45,635	51,678	31,604
Miscellaneous	7,279	8,932	16,211	3,319
Events and meetings	1,373	61,650	63,023	17,608
Support of APPGA	10,000	-	10,000	10,000
Support of Youth STOPAIDS/other donations	990	17,130	18,120	24,455
Rent, rates and services	7,720	-	7,720	10,010
Insurance	574	-	574	719
Depreciation	,1,866	-	1,866	2,029
Legal expenses	-	5,036	5,036	-
IT	8,230	-	8,230	5,850
Other office running costs	4,711	4,518	9,229	7,398
Reallocation for contribution to core costs	(94,657)	94,657	-	-
───────		───────	───────	───────
	257,680	1,108,208	1,365,888	920,412
───────		───────	───────	───────
Governance functions
Meeting and annual report costs	306	-	306	740
Auditor/Independent examiner’s fee	5,100	1,500	6,600	5,100
Other accountancy fees	4,745	-	4,745	1,367
───────		───────	───────	───────
	10,151	1,500	11,651	7,207
───────		───────	───────	───────
Total charitable expenditure	267,831	1,109,708	1,377,539	927,619
═══════		═══════	═══════	═══════

Support costs relate to the staff and running costs of the Charity’s office and are allocated on a basis consistent with the use of resources.

The Auditor and Independent Examiner’s fees payable are shown under governance costs above.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

5. Trustees’ remuneration and expenses

The charity did not pay to its trustees any remuneration. No expenses (2022: £Nil) were reimbursed to trustees for travel expenses during the year.

6. Staff costs and numbers

	2023	2022
	£	£
Salaries and wages	863,905	612,056
Pension	54,011	39,170
Social security costs	84,771	82,751
	─────	─────
	1,002,687	733,977
	═════	═════
The average number of staff employed, based on the full time equivalent,
during the period was:	22	18
	═════	═════

One employee had total employee benefits of £60,000 - £70,000 in the year (2022: one).

The key management personnel of the charity comprise the Executive Director and the Development and Network Manager. The total employee benefits of the key management personnel of the charity were £119,333 (2022: £119,544).

7. Fixed assets

Fixed assets
	Computer
	equipment	Total
	£	£
Cost
At 1 April 2022	26,638	26,638
Additions	1,119	1,119
	─────	─────
At 31 March 2023	27,757	27,757
	─────	─────
Depreciation
At 1 April 2022	23,391	23,391
Charge for the year	1,866	1,866
	─────	─────
At 31 March 2023	25,257	25,257
	─────	─────
Net book value
At 31 March 2023	2,500	2,500
	─────	─────
At 31 March 2022	3,247	3,247
	─────	─────

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

8. Debtors: amounts falling due within one year

Debtors: amounts falling due within one year
	2023	2022
	£	£
Grants and contracts receivable	30,907	10,558
Membership debtors	90,195	65,124
Other debtors	4,849	2,054
Less: provision for doubtful debts	(2,241)	(10,000)
	─────	─────
	123,710	67,736
Accrued income	138,672	12,296
	─────	─────
Total	262,382	80,032
	═════	═════
Creditors: amounts falling due within one year
	2023	2022
	£	£
Taxation and social security	22,922	23,176
Deferred income	395,409	395,386
Sundry creditors and accruals	42,956	53,864
	─────	─────
Total	461,287	472,426
	═════	═════
Deferred income movements
Balance at 1 April 2022	395,386	245,195
Last year recognised in the year	(395,386)	(245,195)
New receipts deferred	395,409	395,386
	─────	─────
Balance at 31 March 2023	395,409	395,386
	═════	═════

9. Creditors: amounts falling due within one year

Deferred income relates to the funds received from donors subject to restrictions that prevents their use until a later date.

10. Lease commitment

The total of future minimum lease payments under non-cancellable operating leases for each of the following periods:

	2023	2022
	£	£
Not later than one year	-	9,240
Later than one year and not later than five years	-	-
	─────	─────
	-	9,240
	═════	═════

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

11. Movements in funds

	Balance at				Balance
	1.04.22	Incoming	Transfers	Outgoing	31.03.23
	£	£	£	£	£
Restricted funds
APPGA	-	38,450	-	(38,452)	(2)
GNP+	5,480	101,830	-	(104,345)	2,965
Action for Global Health	140,995	99,445	(815)	(93,665)	145,960
Advocacy
New Venture Fund–Global Fund	4,683	-	(4,683)	-	-
New Venture Fund–Phase III	15,237	133,342	-	(145,439)	3,140
Botnar Foundation	5,357	49,064	-	(51,243)	3,178
The Global Fund to Fight AIDS,
Tuberculosis and Malaria	3,848	3,743	-	(7,591)	-
WACI Health (ACT A)	8,738	62,532	1,465	(64,930)	7,805
The Wellcome Trust	2,657	-	-	(2,657)	-
The Wellcome Trust
(Future of GHIS)	-	2,679	-	-	2,679
Joseph Rowntree Trust	-	92,700	-	(75,734)	16,966
Love Alliance (Aidsfonds)	-	98,294	-	(104,186)	(5,892)
Restless Development
(GenEndIt Campaign)	-	12,914	-	(12,914)	-
The Bill and Melinda
Gates Foundation	48,810	239,915	815	(262,543)	26,997
Other
Other funders	1,465	-	(1,465)	-	-
UNITAID	9,993	160,617	-	(146,009)	24,601
	───────	───────	───────	───────	───────
	247,263	1,095,525	(4,683)	(1,109,708)	228,397
	───────	───────	───────	───────	───────
Unrestricted funds
General	401,481	113,758	4,683	(267,990)	251,932
	───────	───────	───────	───────	───────
Total funds	648,744	1,209,283	-	(1,377,698)	480,329
	═══════	═══════	═══════	═══════	═══════

Please see Note 3 for descriptions and purposes of the Restricted Funds.

Overheads are allocated on a basis consistent with the use of resources for each of the above named projects undertaken by the Charity.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

11. Movements in funds (continued)

	Balance at				Balance
	1.04.21	Incoming	Transfers	Outgoing	31.03.22
	£	£	£	£	£
Restricted funds
APPGA	387	35,917	-	(36,304)	-
GNP+	1,113	102,806	-	(98,439)	5,480
Action for Global Health	104,373	73,721	-	(37,099)	140,995
Advocacy
MAC Aids Fund	18	-	(18)	-	-
New Venture Fund–Global Fund	4,683	-	-	-	4,683
New Venture Fund–Phase III	(3,003)	123,079	-	(104,839)	15,237
Botnar Foundation	1,009	15,925	-	(11,577)	5,357
The Global Fund to Fight AIDS,
Tuberculosis and Malaria	(2,546)	39,617	-	(33,223)	3,848
WACI Health (ACT A)	-	32,565	-	(23,827)	8,738
The Wellcome Trust	-	49,936	-	(47,279)	2,657
Gates Foundation	43,808	230,492	-	(225,490)	48,810
Other
Other funders	8,887	14,103	-	(21,525)	1,465
UNITAID	22,587	37,626	-	(50,220)	9,993
	───────	───────	───────	───────	───────
	181,316	755,787	(18)	(689,822)	247,263
	───────	───────	───────	───────	───────
Unrestricted funds
Designated	26,870	-	(26,870)	-	-
General	217,432	394,958	26,888	(237,797)	401,481
	───────	───────	───────	───────	───────
	244,302	394,958	18	(237,797)	401,481
	───────	───────	───────	───────	───────
Total funds	425,618	1,150,745	-	(927,619)	648,744
	═══════	═══════	═══════	═══════	═══════

Please see Note 3 for descriptions and purposes of the Restricted Funds.

Overheads are allocated on a basis consistent with the use of resources for each of the above named projects undertaken by the Charity.

The designated fund represented funds held for future activities as approved by the Trustees, and has been released into general funds during 2021/22 in line with the reserves policy set by the Board.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

12. Analysis of net assets between funds

	General	Restricted	Total
	Funds	Funds	Funds
	£	£	£
Tangible fixed assets	2,500	-	2,500
Current assets	315,310	623,806	939,116
Current liabilities	(65,878)	(395,409)	(461,287)
	─────	─────	─────
Net assets at 31 March 2023	251,932	228,397	480,329
	═════	═════	═════
Tangible fixed assets	3,247	-	3,247
Current assets	475,274	642,649	1,117,923
Current liabilities	(77,040)	(395,386)	(472,426)
	─────	─────	─────
Net assets at 31 March 2022	401,481	247,263	648,744
	═════	═════	═════

13. Reconciliation of net movement in funds to net cash flow from operating activities

	2023	2022
	£	£
Net movement in funds	(168,415)	223,126
Add back depreciation	1,866	2,029
(Increase)/decrease in debtors	(182,350)	55,802
(Decrease)/increase in creditors	(11,139)	192,751
	─────	─────
Net cash provided by operating activities	(360,038)	473,708
	═════	═════

14. Pension costs

The charity has arranged a defined contribution pension scheme managed by AVIVA (formerly Friends Provident Group plc). The charity contributes 6% of gross salary for all qualifying employees. The assets of the scheme are held separately from those of the charity. Pension costs charged in the Statement of Financial Activities represent the contributions payable by the charity in the year.

15. Related party transactions

The charity typically draws its trustees from membership organisations as standard, and as a result these entities are related parties. The membership fee charged to these organisations is at the standard rate, and there are no other specific benefits or transactions with the organisations.

During 2023, additional transactions with linked organisations were as follows:

Frontline AIDS – Grant income: £1,698 – Youth Stop AIDS Grant awarded: £18,000 ONE – Direct charitable expenditure: £1,000

There were no other related party transactions during the prior period.

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

16. Comparative Statement of Financial Activities

----- Start of picture text -----
||||| |---|---|---|---| |2022| |Unrestricted Restricted|Total| |£|£|£| |Income| |Contributions from members and observers|23,850|73,721|97,571| |Grants and contracts|369,470|682,066|1,051,536| |Other income|1,500|-|1,500| |Interest income|138|-|138| |───────|───────|───────| |Total|394,958|755,787|1,150,745| |───────|───────|───────| |Expenditure on:| |Charitable activities|230,590|689,822|920,412| |Support costs|7,207|-|7,207| |───────|───────|───────| |Total|237,797|689,822|927,619| |───────|───────|───────| |Net income/(expenditure)|157,161|65,965|223,126| |───────|───────|───────| |Transfers between funds|18|(18)|-| |───────|───────|───────| |Net movement in funds|157,179|65,947|223,126| |───────|───────|───────| |Reconciliation of funds| |Total funds brought forward|244,302|181,316|425,618| |───────|───────|───────| |Total funds carried forward|401,481|247,263|648,744| |═══════|═══════|═══════|

----- End of picture text -----

2023-03-31-accounts

Annual Report and Accounts for Year End March 2023

Contents

Message from the Director

Achievements & highlights 2022-2023

People over Profit

Achievements & highlights 2022-2023

Ensuring Enhanced Quality of Life for people living with and affected by HIV.

Transforming aid, solidarity and development co – operation

What our partners say about us

Oxfam GB

AVAC

Peoples Vaccine Alliance

Restless Development

Avert

Malaria No more

Just Treatment

Areas of work

People over Profit

Ensuring Enhanced Quality of Life for people living with and affected by HIV

Reduction of HIV-related structural barriers

Transforming aid, solidarity and development Co-operation

Meaningful civil society and community involvement in global health governance/ Pandemic Preparedness and Response

Anti-Oppression Framework

Media Coverage

Membership Engagement

Hosting role

Plans for 2023-24

People Over Profit

Ensuring Enhanced Quality of Life for people living with and affected by HIV

Transforming aid, solidarity and development co-operation

STOPAIDS Team

Structure, governance and management

REGISTERED OFFICE:

AUDITORS

PRINCIPAL OFFICERS

BANKERS

Governing Document

Organisational Structure

Key Management Personnel Remuneration

Risk Management

Fundraising standards information

OBJECTIVES AND ACTIVITIES

Public Benefit Statement:

Financial review

Reserves

Statement of Trustees Responsibilities

Independent Auditor ’s Report to the members of STOPAIDS

Opinion

Basis for opinion

Conclusions relating to going concern

Other information

Opinions on other matters prescribed by the Companies Act 2006

Matters on which we are required to report by exception

Independent Auditors’ Report to the members of STOPAIDS (continued)

Matters on which we are required to report by exception (continued)

Responsibilities of trustees

Auditor’s responsibilities for the audit of the financial statements

Use of our report

STOPAIDS

Statement of Financial Activities (including Income and Expenditure Account) for the year ended 31 March 2023

STOPAIDS

Balance Sheet As at 31 March 2023

Approved and signed on behalf of the Executive Committee on 14th September 2023

STOPAIDS

Statement of Cash Flows for the year ended 31 March 2023

STOPAIDS

Notes to the accounts for the year ended 31 March 2023

1. General information and basis of preparation

2.

(a) Basis of accounting

(b) Fund accounting

(c) Income

(d) Expenditure

STOPAIDS

Notes to the accounts (continued) for the year ended 31 March 2023

(d) Expenditure (continued)

(e) Fixed assets

(f) Foreign currency

(g) Debtors and creditors receivable / payable within one year